Titre:
  • Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.
Auteur:Salgado, Roberto; Denkert, Carsten; Campbell, Christine; Savas, Peter; Nucifero, Paolo; Aura, Claudia Monica; De Azambuja, Evandro; Eidtmann, Holger; Ellis, Catherine; Baselga, José; Piccart-Gebhart, Martine; Michiels, Stefan; Bradbury, Ian; Sotiriou, Christos; Loi, Sherene
Informations sur la publication:JAMA oncology, 1, 4, page (448-454)
Statut de publication:Publié, 2015-07
Sujet CREF:Cancérologie
Médecine pathologie humaine
Sciences bio-médicales et agricoles
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:2374-2437
info:doi/10.1001/jamaoncol.2015.0830
info:pii/2279849
info:scp/84982889739
info:pmid/26181252